Arena Pharmaceuticals is committed to supporting IME programs that foster the exchange of scientific and clinical information and improve patient care.
We invite you to submit funding requests for independent, objective, educational programs and activities that provide legitimate education of healthcare professionals and/or the public in the therapeutic areas of GI (Ulcerative Colitis, Crohn's Disease, Eosinophilic Esophagitis, Pain with IBS and IBD); Dermatology (Atopic Dermatitis, Alopecia Areata); Cardiovascular (Acute Heart Failure).
Arena Pharmaceuticals' educational grants must comply with the applicable requirements, guidelines, or standards issued by the Food and Drug Administration, the Office of Inspector General, the Pharmaceutical Research and Manufacturers of America, the American Medical Association, the Accreditation Council for Continuing Medical Education, and other nationally-recognized accrediting bodies.
Grant requests may come from academic institutions, state or national medical associations or societies, disease foundations and associations, patient associations, or other educational providers. For academic institutions, the University Grants Office should apply for the grant, rather than an individual department or research group. Grants will not be given to individuals. Arena Pharmaceuticals does not fund noneducational expenses.
Preference will be given to requests that are ACCME accredited, contain an educational needs assessment, and propose to evaluate post-program educational outcomes. Grants should be submitted 60 days or more prior to the program start date.
Each request for an educational grant must include:
If you are a new user, click the Register button above to register a new account. If you are a returning user, click the Sign In button to login.
Contact Arena Pharmaceuticals:
For Technical Support, please contact SteepRock Client Services:
Phone: +1 718-576-1406 (M-F 8am - 6pm US ET)